The Patent Finder

Terms ending in 2037

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,323,0281,3,4-Thiadiazole Compounds and Their Use in Treating Cancer
In force
 · High confidence
Cancer Research Technology LimitedIn forceHigh confidence
US 11,753,4051,3,4-Thiadiazole Compounds and Their Use in Treating Cancer
In force
 · High confidence
AstraZeneca AB and Cancer Research Technology LimitedIn forceHigh confidence
US 10,894,789Halo-Substituted Piperidines as Orexin Receptor Modulators
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 11,434,236Halo-Substituted Piperidines as Orexin Receptor Modulators
In force
 · High confidence
Niuvera Bio, Inc.In forceHigh confidence
US 10,407,404Physical Form of a SGR Modulator
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 10,125,135Chemical Compounds
Grace period ended Nov 13, 2026 · lapse expected
 · Low confidence
AstraZeneca UK LimitedGrace period ended Nov 13, 2026
lapse expected
Low confidence
US 10,729,655Orally Disintegrating Tablets
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 9,840,518MCL-1 Inhibitors and Methods of Use Thereof
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 10,196,404MCL-1 Inhibitors and Methods of Use Thereof
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 10,889,594MCL-1 Inhibitors and Methods of Use Thereof
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
14 more term ends in 2037 · Pro
10 of 24 patents shown. Soonest term end first, then patent number.
Pro members see all 24.
Upgrade to Pro
21 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited